Overview

Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma

Status:
Completed

Trial end date:
2008-04-01

Target enrollment:

Participant gender:

Summary

This study is designed to evaluate the bronchodilatory efficacy of indacaterol maleate 500 μg/mometasone furoate 400 μg via the Twisthaler® device in adult patients with persistent asthma.

Phase:

Phase 2

Details

Lead Sponsor:

Novartis

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Maleic acid
Mometasone Furoate
Salmeterol Xinafoate